Survival analysis of 306 European Spanish patients with systemic lupus erythematosus
- PMID: 9607639
- DOI: 10.1191/096120398678919930
Survival analysis of 306 European Spanish patients with systemic lupus erythematosus
Abstract
Objective: To describe survival of lupus in South European Spanish patients.
Patients and methods: Observational study of all SLE Spanish patients seen at three University Hospitals between 1975 and 1993. The charts of all patients were retrospectively reviewed. Sixty-four clinic and laboratory variables were extracted from charts. Univariate analysis, multivariate Cox proportional hazard regression analysis, actuarial life tables and multiple logistic regression analysis were used to calculate survival probability and identify variables associated with survival.
Results: Three hundred and six (275 female and 31 male) patients were identified. Their mean age at diagnosis was 31.9 years (range 4 to 85). The mean duration of followup was 79 (1-126) months. Thirty-one patients died. The most common cause of death was infection (29%). Five, 10 and 15 years' survival rate was 90%+/-0.0158, 85%+/-0.0262 and 80%+/-0.0413, respectively. Log-rank analysis showed that male sex, proteinuria and nephropathy at diagnosis were associated with poor survival. By univariate and multivariate analysis male gender, nephropathy and CNS involvement were associated with worse survival.
Conclusion: In SLE patients from Spain, rate of survival is similar to other Caucasian patients, and better than other ethnic groups of Spanish ancestry. Other factors rather than genetic factors could explain our findings.
Similar articles
-
Survival of Mexican patients with paediatric-onset systemic lupus erythematosus and abnormal electroencephalogram.Allergol Immunopathol (Madr). 2013 Mar-Apr;41(2):108-13. doi: 10.1016/j.aller.2011.11.007. Epub 2012 Feb 7. Allergol Immunopathol (Madr). 2013. PMID: 22316551
-
Survival analysis and prognostic indicators of systemic lupus erythematosus in Pakistani patients.Lupus. 2009 Aug;18(9):848-55. doi: 10.1177/0961203309103410. Lupus. 2009. PMID: 19578112
-
Association between serum total cholesterol level and renal outcome in systemic lupus erythematosus.Arthritis Rheum. 2006 Jul;54(7):2211-9. doi: 10.1002/art.21929. Arthritis Rheum. 2006. PMID: 16802357
-
The incidence and prevalence of systemic lupus erythematosus in Thrace, 2003-2014: A 12-year epidemiological study.Lupus. 2016 Jan;25(1):102-9. doi: 10.1177/0961203315603141. Epub 2015 Sep 7. Lupus. 2016. PMID: 26345673 Review.
-
Causes of death and prognostic factors in Thai patients with systemic lupus erythematosus.Asian Pac J Allergy Immunol. 2002 Jun;20(2):85-91. Asian Pac J Allergy Immunol. 2002. PMID: 12403192 Review.
Cited by
-
Androgen-Induced Immunosuppression.Front Immunol. 2018 Apr 17;9:794. doi: 10.3389/fimmu.2018.00794. eCollection 2018. Front Immunol. 2018. PMID: 29755457 Free PMC article. Review.
-
Contribution of the initial features of systemic lupus erythematosus to the clinical evolution and survival of a cohort of Mediterranean patients.Ann Rheum Dis. 2003 Sep;62(9):859-65. doi: 10.1136/ard.62.9.859. Ann Rheum Dis. 2003. PMID: 12922959 Free PMC article.
-
Optimising testing for phospholipid antibodies.J Clin Pathol. 2001 Sep;54(9):693-8. doi: 10.1136/jcp.54.9.693. J Clin Pathol. 2001. PMID: 11533076 Free PMC article.
-
Development and Verify of Survival Analysis Models for Chinese Patients With Systemic Lupus Erythematosus.Front Immunol. 2022 Jun 24;13:900332. doi: 10.3389/fimmu.2022.900332. eCollection 2022. Front Immunol. 2022. PMID: 35812398 Free PMC article.
-
Pneumococcal vaccination in autoimmune rheumatic diseases.RMD Open. 2017 Sep 14;3(2):e000484. doi: 10.1136/rmdopen-2017-000484. eCollection 2017. RMD Open. 2017. PMID: 28955497 Free PMC article. Review.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical